Related Experiment Video
Updated: Feb 17, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
Published on: February 7, 2021
Polymeric gels for intravaginal drug delivery
Michael T Cook1, Marc B Brown2
1Department of Pharmacy, Pharmacology, and Postgraduate Medicine, University of Hertfordshire, Hatfield AL10 9AB, United Kingdom.
Intravaginal drug delivery offers local or systemic effects, but poor retention and irritation are challenges. This review explores polymeric gels for improved vaginal drug delivery, focusing on retention and controlled release.
Area of Science:
- Pharmacology
- Biomaterials Science
- Gynecology
Background:
- Intravaginal drug delivery provides local effects or systemic absorption, bypassing first-pass metabolism.
- The vaginal route presents challenges including poor retention due to clearance and potential for adverse reactions.
- Gel formulations offer ease of application but suffer from poor retention and lack of controlled drug release.
Purpose of the Study:
- To review the anatomy and physiology of the vagina relevant to drug delivery.
- To discuss medical applications of vaginally administered medicines.
- To overview polymeric gels for intravaginal drug delivery, focusing on retention, controlled release, sensorial properties, user compliance, and marketing approval barriers.
Main Methods:
- Literature review focusing on vaginal anatomy, physiology, and drug delivery principles.
- Analysis of polymeric gel formulations for intravaginal administration.
- Discussion of factors influencing user compliance and regulatory considerations.
Main Results:
- Vaginal anatomy and physiology significantly impact drug absorption and retention.
- Polymeric gels show promise for enhancing retention and controlling drug release.
- Sensorial properties and user compliance are critical for successful product development.
Conclusions:
- Optimizing vaginal gel formulations is crucial for effective drug delivery.
- Addressing retention, controlled release, and user acceptance is key to overcoming challenges.
- Understanding regulatory pathways is essential for marketing approval of intravaginal products.
Related Concept Videos
Intrauterine Drug Delivery Systems
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Rate-Programmed II
Modified-Release Drug Delivery Systems: Stimuli-Activated
Oral Drug Delivery Systems: Delayed-Release Systems
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

